Elvis J. Alonso

Vice President, Research And Early Development Operations at Alnylam Pharmaceuticals

Elvis J. Alonso possesses extensive experience in the pharmaceutical and biotech industries, with a career spanning over two decades. Currently serving as Vice President of Research and Early Development Operations at Alnylam Pharmaceuticals since August 2017, Elvis has held various roles including Senior Director and Director within the same department. Prior to Alnylam, Elvis contributed to Moderna Therapeutics as Director of Research Operations, and Takeda Pharmaceuticals as Associate Director of Discovery Operations. Earlier career highlights include strategic consulting for Baxter International Inc. and delivering comprehensive marketing strategies as Senior Manager of Global Marketing - Vaccines. Elvis also has a strong foundation in oncology research from positions at Millennium Pharmaceuticals and Dana-Farber Cancer Institute. Educational qualifications include an MBA from D'Amore-McKim School of Business at Northeastern University and a BA in Biochemistry and Molecular Biology from Boston University.

Location

Cambridge, United States

Links

Previous companies


Org chart


Teams


Offices


Alnylam Pharmaceuticals

32 followers

Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.


Industries

Employees

1,001-5,000

Links